3 clinical trials found.
-
A Phase 2 12-Week Adaptive Open Label Sequential Cohort Trial to Evaluate the Efficacy Safety Tolerability and Pharmacokinetics of PF06730512 Following Multiple Doses in Adult Subjects with Focal Segmental Glomerulosclerosis (FSGS)
The purpose of this research study is to learn about the effects, overall safety, how well people can tolerate (tolerability) the study drug (PF-06730512), and ...Phase
TRIAL ROLE: Principal Investigator
-
A randomized treatment open-label dose-blinded parallel group three arm proof-of-concept clinical trial to investigate the efficacy and safety of LNP023 compared with rituximab in the treatment of subjects with idiopathic membranous nephropathy
The purpose of the study is to find out if the drug called “LNP023” is safe and has beneficial effects in people who have membranous ...Phase
TRIAL ROLE: Sub Investigator
-
A Phase 3b Multicenter Randomized Double-blind Placebo-controlled Study Evaluating the Efficacy and Safety of Subcutaneously Administered Guselkumab in Improving the Signs and Symptoms and Inhibiting Radiographic Progression in Participants with Activ
The purpose of this study is to see if guselkumab is safe and useful for treating patients with active psoriatic arthritis (PSA). Guselkumab is a ...Phase
TRIAL ROLE: Sub Investigator
